ORI Updates

Mr. Shiladitya Sen engaged in research misconduct by knowingly and intentionally falsifying and/or fabricating data reported in the following published paper, his Ph.D. thesis, a poster presentation, and his mentor’s grant applications submitted to NIGMS, NIH.

Maria Cristina Miron Elqutub engaged in research misconduct by recording dates and providing her own blood samples to cause these samples to be falsely labeled as samples from ninety-eight (98) study subjects in a cancer genetics study involving human blood samples.

The Office of Research Integrity (ORI) has appointed Dr. Ranjini Ambalavanar as Acting Director of the Division of Investigative Oversight. Since joining ORI in 2009, she has handled more than 100 allegations of research misconduct. She replaces Dr. Ann Hohmann, who successfully completed her 120-day detail appointment.

Dr. H.M. Krishna Murthy committed research misconduct in research supported by PHS grants. Dr. Murthy requested a hearing before an Administrative Law Judge (ALJ) of the Departmental Appeals Board to dispute the findings. The ALJ issued a recommended decision to the Acting Assistant Secretary for Health (ASH) granting summary judgment in favor of ORI and sustaining ORI’s proposal to impose a ten-year debarment and a ten-year ban...

Because Dr. Brandi Baughman knew when she signed the 2017 Agreement with ORI that there was an additional paper with falsified figures, she agreed to exclude herself voluntarily from any contracting or subcontracting with any agency of the United States Government...

ORI found that Dr. Bhagavathi Narayanan engaged in research misconduct by knowingly and intentionally falsifying and/or fabricating data reported in the following three published papers and seven grant applications submitted to NIH.

Indiana University and Purdue University are co-sponsoring an ORI funded conference on plagiarism on April 3-5, 2018.

ORI found that Respondent engaged in research misconduct by intentionally, knowingly, or recklessly reporting falsified and/or fabricated data and/or falsifying and/or fabricating data in two (2) papers:

ORI has funding opportunity for research on research integrity and the responsible conduct of research. Deadline: March 23, 2018.

ORI has funding opportunity for grants to hold conferences on research integrity and the responsible conduct of research. Deadline: March 26, 2018.